BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has rescheduled its fourth quarter and full year 2019 earnings conference call to Thursday, March 26, 2020, due to scheduling conflicts.
March 18, 2020
· 3 min read